CSL Limited
CSL
Clasificación en acciones
#363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Precio por acción
$138.58
Capitalización bursátil
$66.50B
Cambio (1 día)
0.72%
Cambio (1 año)
-2.29%
País
AU
Comercio CSL Limited (CSL)
Categoría
Healthcare
Historial de desdoblamientos de acciones de CSL Limited (CSL)
La acción CSL Limited (símbolo: CSL) tuvo un total de 1 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 18, 2007.
Una acción CSL comprada antes de Oct 18, 2007 equivaldría hoy a 3 acciones CSL.
El desdoblamiento más reciente ocurrió el Oct 18, 2007.
Una acción CSL comprada antes de Oct 18, 2007 equivaldría hoy a 3 acciones CSL.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
